Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The scope of the trial is to determine the preference of patients, after randomization and
cross-over, for one of the two treatments.
Another objective of the trial is to assess and compare the safety of each treatment.